MAD2L1 and ovarian cancer: Interestingly, loss of miR-493-3p appeared to occur more frequently in HGSC than benign epithelium or less aggressive ovarian cancer forms, which can provide one explanation for the elevated Mad2 levels found in disseminated cancers.